Bellevue Group AG Has $9.63 Million Stock Position in Phreesia, Inc. (NYSE:PHR)

Bellevue Group AG cut its stake in shares of Phreesia, Inc. (NYSE:PHR) by 4.7% in the third quarter, Holdings Channel reports. The firm owned 422,406 shares of the company’s stock after selling 20,935 shares during the quarter. Bellevue Group AG’s holdings in Phreesia were worth $9,627,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. International Assets Investment Management LLC boosted its holdings in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the last quarter. nVerses Capital LLC raised its position in shares of Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after acquiring an additional 1,300 shares during the period. Quadrature Capital Ltd bought a new position in Phreesia during the 1st quarter worth approximately $202,000. Lombard Odier Asset Management USA Corp acquired a new position in Phreesia during the second quarter valued at approximately $202,000. Finally, Point72 DIFC Ltd acquired a new stake in Phreesia in the second quarter worth $209,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Stock Up 3.6 %

Shares of PHR opened at $21.03 on Friday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. Phreesia, Inc. has a twelve month low of $14.55 and a twelve month high of $29.16. The company has a 50 day moving average of $20.43 and a 200-day moving average of $21.86.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. The business had revenue of $102.12 million during the quarter, compared to the consensus estimate of $101.76 million. On average, sell-side analysts predict that Phreesia, Inc. will post -1.23 EPS for the current year.

Analyst Ratings Changes

PHR has been the subject of several research analyst reports. JPMorgan Chase & Co. boosted their price target on shares of Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, September 9th. Robert W. Baird increased their price target on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a report on Friday, September 6th. DA Davidson reiterated a “buy” rating and set a $32.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Finally, Truist Financial raised their target price on shares of Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, September 6th. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and a consensus target price of $29.42.

Insider Activity

In other news, CEO Chaim Indig sold 5,295 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $123,108.75. Following the completion of the sale, the chief executive officer now owns 1,223,736 shares of the company’s stock, valued at approximately $28,451,862. This represents a 0.43 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $25,488.36. Following the completion of the transaction, the general counsel now directly owns 119,791 shares of the company’s stock, valued at $2,519,204.73. This represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 29,997 shares of company stock worth $667,943 in the last quarter. Corporate insiders own 5.80% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.